We are live on ! Find out more
FCMT

Founders Capital Management (Texas) Portfolio holdings

AUM $231M
1-Year Est. Return 61.68%
This Fund
S&P 500
This Quarter Est. Return
+8.26%
1 Year Est. Return
+61.68%
3 Year Est. Return
+118.08%
5 Year Est. Return
+149.3%
10 Year Est. Return
–
AUM
$121M
AUM Growth
+$7.32M
Cap. Flow
-$984K
Cap. Flow %
-0.81%
Top 10 Hldgs %
40.5%
Holding
323
New
12
Increased
40
Reduced
40
Closed
16

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$909K
2
HD icon
Home Depot
HD
+$484K
3
LOW icon
Lowe's Companies
LOW
+$479K
4
IBB icon
iShares Biotechnology ETF
IBB
+$191K
5
QQQ icon
Invesco QQQ Trust
QQQ
+$67.8K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$925K
2
KMI icon
Kinder Morgan
KMI
+$774K
3
SCHF icon
Schwab International Equity ETF
SCHF
+$278K
4
USCR
U S Concrete, Inc.
USCR
+$230K
5
T icon
AT&T
T
+$166K

Sector Composition

Rank Sector Weight
1 Technology 23.93%
2 Energy 12.25%
3 Healthcare 10.83%
4 Financials 10.6%
5 Industrials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORN icon
151
Orion Group Holdings
ORN
$418M
$30K 0.02%
4,000
+1,000
+33% +$8.6K
HES
152
DELISTED
Hess
HES
$29K 0.02%
400
– –
IYW icon
153
iShares US Technology ETF
IYW
$25.2B
$29K 0.02%
600
– –
BKR icon
154
Baker Hughes
BKR
$61.1B
$28K 0.02%
820
– –
GD icon
155
General Dynamics
GD
$106B
$28K 0.02%
135
+10
+8% +$1.96K
LQD icon
156
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$28K 0.02%
240
-52
-18% -$5.99K
PB icon
157
Prosperity Bancshares
PB
$8.89B
$28K 0.02%
400
– –
EGY icon
158
Vaalco Energy
EGY
$594M
$27K 0.02%
10,000
+2,000
+25% +$5.27K
CELG
159
DELISTED
Celgene Corp
CELG
$27K 0.02%
300
– –
NLY icon
160
Annaly Capital Management
NLY
$17.4B
$26K 0.02%
625
– –
AGTC
161
DELISTED
Applied Genetic Technologies Corporation
AGTC
$26K 0.02%
3,600
-400
-10% -$1.75K
IYM icon
162
iShares US Basic Materials ETF
IYM
$1.25B
$25K 0.02%
250
– –
NGG icon
163
National Grid
NGG
$81.3B
$24K 0.02%
518
– –
DB icon
164
Deutsche Bank
DB
$71.5B
$23K 0.02%
2,000
– –
IHI icon
165
iShares US Medical Devices ETF
IHI
$3.38B
$23K 0.02%
600
– –
MAIN icon
166
Main Street Capital
MAIN
$5.48B
$23K 0.02%
600
– –
MU icon
167
Micron Technology
MU
$991B
$23K 0.02%
+500
New +$25.2K
HWCC
168
DELISTED
Houston Wire & Cable Company
HWCC
$23K 0.02%
3,000
– –
AEHR icon
169
Aehr Test Systems
AEHR
$3.36B
$22K 0.02%
10,000
+2,000
+25% +$4.95K
MDT icon
170
Medtronic
MDT
$112B
$22K 0.02%
225
– –
YUMC icon
171
Yum China
YUMC
$16.3B
$22K 0.02%
620
– –
ITI
172
DELISTED
Iteris, Inc.
ITI
$22K 0.02%
4,000
– –
TTOO
173
DELISTED
T2 Biosystems, Inc
TTOO
$22K 0.02%
1
– –
APT icon
174
Alpha Pro Tech
APT
$53.1M
$21K 0.02%
6,000
– –
AXTI icon
175
AXT Inc
AXTI
$5.8B
$21K 0.02%
3,000
– –
5 6
7
8 9

Similar funds

CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
TW
Titan Wealth St Peter Port $232M AUM
RWMG
Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
PWA
Prairie Wealth Advisors Omaha, Nebraska $231M AUM 23.67% 1-Year Est. Return
RF
rebel Financial Groveport, Ohio $231M AUM 12.5% 1-Year Est. Return

Founders Capital Management (Texas)'s Q3 2018 Portfolio in Review

As of Q3 2018, Founders Capital Management (Texas) held 323 positions worth $121M, up 6.4% from $114M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Founders Capital Management (Texas)'s Q3 2018 filing shows 12 new, 40 increased, 40 reduced and 16 closed positions. Its largest new stake was McDermott International: 2,400 shares worth $44K. The largest sale was Novartis, an estimated $925K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Energy and Healthcare.

  • Founders Capital Management (Texas)'s largest Q3 2018 buy was McDermott International: 2,400 shares worth $44K.
  • Founders Capital Management (Texas) added most to Pfizer in Q3 2018, an estimated $909K increase.
  • Founders Capital Management (Texas)'s biggest Q3 2018 reduction was Kinder Morgan, cutting an estimated $774K.
  • Founders Capital Management (Texas) fully exited Novartis in Q3 2018, selling an estimated $925K.
  • Founders Capital Management (Texas)'s ten largest holdings make up 41% of its $121M portfolio in Q3 2018.
  • Founders Capital Management (Texas) opened 12 new positions and closed 16 in Q3 2018.
  • Founders Capital Management (Texas)'s portfolio value rose 6.4% quarter-over-quarter to $121M.

Based on Founders Capital Management (Texas)'s 13F filing for Q3 2018, filed 5 Oct 2018.